MP
Live price temporarily unavailable.
Price history
Maplight Therapeutics Inc (MPLT) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: October 27, 2025 · $17.00 offering · NASDAQ · View IPO details →
Recent News (2)
-
Morgan Stanley downgrades MapLight Therapeutics stock rating on trial results Morgan Stanley downgrades MapLight Therapeutics stock rating on trial results
-
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia The trial, designed and sized to support registration, met its primary endpoint, with the 210/3 mg BID dose demonstrating a statistically significant improvement in PANSS total score compared to place…
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International